Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (38 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/23/2026 | 178,715 | 0.3% | 394,200 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 148,577 | 0.2% | 379,371 | 9/30/2025 |
| 2025 Q2 | 7/18/2025 | 146,645 | 0.2% | 329,391 | 6/30/2025 |
| 2025 Q1 | 4/23/2025 | 70,784 | 0.1% | 146,000 | 3/31/2025 |
| 2024 Q4 | 1/23/2025 | 115,477 | 0.2% | 286,756 | 12/31/2024 |
| 2024 Q3 | 10/29/2024 | 137,928 | 0.3% | 296,568 | 9/30/2024 |
| 2024 Q2 | 7/23/2024 | 173,525 | 0.4% | 370,211 | 6/30/2024 |
| 2024 Q1 | 4/24/2024 | 193,902 | 0.4% | 463,869 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 186,284 | 0.5% | 457,824 | 12/31/2023 |
| 2023 Q3 | 10/24/2023 | 150,550 | 0.4% | 432,937 | 9/30/2023 |
| 2023 Q2 | 7/24/2023 | 143,021 | 0.4% | 406,414 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 140,779 | 0.4% | 446,817 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 136,292 | 0.4% | 471,957 | 12/31/2022 |
| 2022 Q3 | 12/1/2022 | 98,162 | 0.3% | 339,030 | 9/30/2022 |
| 2022 Q2 | 12/1/2022 | 71,580 | 0.2% | 254,027 | 6/30/2022 |
| 2022 Q1 | 12/1/2022 | 61,805 | 0.1% | 236,832 | 3/31/2022 |
| 2021 Q4 | 12/1/2022 | 43,551 | 0.1% | 198,318 | 12/31/2021 |
| 2021 Q3 | 12/1/2022 | 36,812 | 0.1% | 202,955 | 9/30/2021 |
| 2021 Q2 | 12/1/2022 | 40,950 | 0.1% | 203,087 | 6/30/2021 |
| 2021 Q1 | 12/1/2022 | 37,927 | 0.1% | 176,492 | 3/31/2021 |
| 2020 Q4 | 12/1/2022 | 68,184 | 0.2% | 288,497 | 12/31/2020 |
| 2020 Q3 | 1/19/2021 | 96,844 | 0.3% | 355,889 | 9/30/2020 |
| 2020 Q2 | 1/19/2021 | 89,517 | 0.3% | 308,352 | 6/30/2020 |
| 2020 Q1 | 1/19/2021 | 19,029 | 0.1% | 79,973 | 3/31/2020 |
| 2019 Q4 | 1/19/2021 | 7,149 | 0.0% | 32,648 | 12/31/2019 |
| 2019 Q3 | 1/19/2021 | 4,863 | 0.0% | 28,710 | 9/30/2019 |
| 2019 Q2 | 1/19/2021 | 6,914 | 0.0% | 37,692 | 6/30/2019 |
| 2019 Q1 | 1/19/2021 | 7,540 | 0.0% | 40,986 | 3/31/2019 |
| 2018 Q4 | 1/19/2021 | 4,176 | 0.0% | 25,203 | 12/31/2018 |
| 2018 Q3 | 1/19/2021 | 7,174 | 0.0% | 37,215 | 9/30/2018 |
| 2018 Q2 | 1/19/2021 | 5,878 | 0.0% | 34,579 | 6/30/2018 |
| 2018 Q1 | 1/19/2021 | 5,968 | 0.0% | 36,628 | 3/31/2018 |
| 2017 Q4 | 1/19/2021 | 4,000 | 0.0% | 26,688 | 12/31/2017 |
| 2017 Q3 | 1/19/2021 | 2,382 | 0.0% | 15,672 | 9/30/2017 |
| 2017 Q2 | 1/19/2021 | 2,013 | 0.0% | 15,633 | 6/30/2017 |
| 2017 Q1 | 1/19/2021 | 105 | 0.0% | 961 | 3/31/2017 |
| 2014 Q1 | 5/7/2014 | 131 | 0.0% | 1,849 | 3/31/2014 |
| 2013 Q4 | 2/4/2014 | 97 | 0.0% | 1,307 | 12/31/2013 |